| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $43.3M | +26.5% |
| Cost of Revenue | $25.6M | +7.1% |
| Gross Profit | $17.7M | +71.5% |
| R&D Expense | $114K | -48.1% |
| SG&A Expense | $9.3M | -2.9% |
| Operating Income | -$2.2M | +79.7% |
| Pre-tax Income | -$1.8M | +82.7% |
| Income Tax | $60K | +297.0% |
| Net Income | -$1.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.3M | +10.2% |
| Accounts Receivable | $1.8M | +72.4% |
| Inventory | $6.0M | -5.5% |
| Current Assets | $18.0M | +10.0% |
| Total Assets | $19.3M | +6.8% |
| Current Liabilities | $5.9M | +35.3% |
| Total Liabilities | $6.1M | +31.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $866K | +108.0% |
| Capital Expenditures | $25K | -82.8% |
| Investing Cash Flow | -$25K | -103.6% |
| Financing Cash Flow | -$33K | -21.7% |
| Free Cash Flow | $841K | +107.7% |
| +82.1% |
| EPS (Basic) | -$0.18 | +83.5% |
| Stockholders' Equity |
| $13.2M |
| -1.6% |